Amgen and Pfizer appoint new Science executives
European Pharmaceutical Review
NOVEMBER 21, 2024
Dr Boshoff will begin this new role on 1 January 2025 and will oversee all R&D functions across every therapeutic area in the company. He earned his medical degree from University of Pretoria in South Africa, a doctorate PhD from the Institute of Cancer Research in London. Academy of Medical Sciences. “I Pfizer Inc.
Let's personalize your content